“…The Consortium for Spinal Cord Medicine’s recent Clinical Practice Guidelines for diagnosis and management of CMD in SCI ( Nash et al, 2019 ) note a high prevalence of obesity and unique clustering of CMD risk factors related to fat metabolism ( Libin et al, 2013 ). Unique dyslipidemia following SCI includes an increased adiposity per unit body mass index (BMI) ( Spungen et al, 2000 ; Clasey and Gater, 2005 ; Gorgey and Gater, 2011 ; Gorgey et al, 2011 ; Yarar-Fisher et al, 2013 ; Beck et al, 2014 ; Cirnigliaro et al, 2015 ), reduced high-density lipoproteins (HDL) ( Bauman et al, 1999 ; Myers et al, 2007 ; Groah et al, 2009 ; Wahman et al, 2010 ), elevated fasted triglyceride (TAG) ( Bauman et al, 1999 ; Myers et al, 2007 ; Groah et al, 2009 ; Wahman et al, 2010 ), and exaggerated postprandial lipemia ( Nash et al, 2005 ; Emmons et al, 2010 , 2014 ; Ellenbroek et al, 2014 ). Despite the plausible dietary contributions to dyslipidemia in SCI ( Bigford and Nash, 2017 ), little is known about the acute physiological and fat trafficking responses to feeding in SCI persons.…”